Metastatic Tumor Burden and Loci as Predictors of First Line Sunitinib Treatment Efficacy in Patients with Renal Cell Carcinoma

The aim of this study was to investigate the prognostic impact of baseline tumor burden and loci on the efficacy of first line renal cancer treatment with sunitinib. Baseline and on-treatment CT scans were evaluated. Both the Kaplan-Meier and Weibull modelling survival estimators have been used to d...

Descripción completa

Detalles Bibliográficos
Autores principales: Czarnecka, Anna M., Brodziak, Anna, Sobczuk, Pawel, Dendek, Cezary, Labochka, Dominika, Korniluk, Jan, Bartnik, Ewa, Szczylik, Cezary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533291/
https://www.ncbi.nlm.nih.gov/pubmed/31123336
http://dx.doi.org/10.1038/s41598-019-44226-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533291/
https://www.ncbi.nlm.nih.gov/pubmed/31123336
http://dx.doi.org/10.1038/s41598-019-44226-y

Ejemplares similares